Literature DB >> 17588180

Docking studies on kinesin spindle protein inhibitors: an important cooperative 'minor binding pocket' which increases the binding affinity significantly.

Cheng Jiang1, Yadong Chen, Xiaojian Wang, Qidong You.   

Abstract

Fifteen KSP inhibitors were docked into the receptor and the binding mode was analyzed for the first time. It was considered that in addition to the main binding pocket all the inhibitors merged in, there exists a cooperative minor binding pocket, which could be explored for significantly increased binding affinity. In addition, a good linear relationship between the biological activities and the lowest binding free energies has also been found. This may help in predicting the binding affinity of newly designed KSP inhibitors.

Mesh:

Substances:

Year:  2007        PMID: 17588180     DOI: 10.1007/s00894-007-0219-2

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  20 in total

1.  Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen.

Authors:  T U Mayer; T M Kapoor; S J Haggarty; R W King; S L Schreiber; T J Mitchison
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

Review 2.  Microtubule motors in mitosis.

Authors:  D J Sharp; G C Rogers; J M Scholey
Journal:  Nature       Date:  2000-09-07       Impact factor: 49.962

3.  Inhibition of a mitotic motor protein: where, how, and conformational consequences.

Authors:  Youwei Yan; Vinod Sardana; Bei Xu; Carl Homnick; Wasyl Halczenko; Carolyn A Buser; Michael Schaber; George D Hartman; Hans E Huber; Lawrence C Kuo
Journal:  J Mol Biol       Date:  2004-01-09       Impact factor: 5.469

Review 4.  Kinesin motors and disease.

Authors:  Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  Trends Cell Biol       Date:  2002-12       Impact factor: 20.808

Review 5.  Processive and nonprocessive models of kinesin movement.

Authors:  Sharyn A Endow; Douglas S Barker
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

6.  Inhibitors of human mitotic kinesin Eg5: characterization of the 4-phenyl-tetrahydroisoquinoline lead series.

Authors:  Christine M Tarby; Robert F Kaltenbach; Tram Huynh; Andrew Pudzianowski; Henry Shen; Marie Ortega-Nanos; Steven Sheriff; John A Newitt; Patricia A McDonnell; Neil Burford; Craig R Fairchild; Wayne Vaccaro; Zhong Chen; Robert M Borzilleri; Joseph Naglich; Louis J Lombardo; Marco Gottardis; George L Trainor; Deborah L Roussell
Journal:  Bioorg Med Chem Lett       Date:  2006-02-03       Impact factor: 2.823

7.  Kinesin spindle protein (KSP) inhibitors. Part 3: synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubility.

Authors:  Robert M Garbaccio; Mark E Fraley; Edward S Tasber; Christy M Olson; William F Hoffman; Kenneth L Arrington; Maricel Torrent; Carolyn A Buser; Eileen S Walsh; Kelly Hamilton; Michael D Schaber; Christine Fernandes; Robert B Lobell; Weikang Tao; Vicki J South; Youwei Yan; Lawrence C Kuo; Thomayant Prueksaritanont; Donald E Slaughter; Cathy Shu; David C Heimbrook; Nancy E Kohl; Hans E Huber; George D Hartman
Journal:  Bioorg Med Chem Lett       Date:  2006-01-24       Impact factor: 2.823

8.  Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP.

Authors:  Christopher D Cox; Michael J Breslin; Brenda J Mariano; Paul J Coleman; Carolyn A Buser; Eileen S Walsh; Kelly Hamilton; Hans E Huber; Nancy E Kohl; Maricel Torrent; Youwei Yan; Laurence C Kuo; George D Hartman
Journal:  Bioorg Med Chem Lett       Date:  2005-04-15       Impact factor: 2.823

9.  A novel action of terpendole E on the motor activity of mitotic Kinesin Eg5.

Authors:  Junko Nakazawa; Junichiro Yajima; Takeo Usui; Masashi Ueki; Akira Takatsuki; Masaya Imoto; Yoko Y Toyoshima; Hiroyuki Osada
Journal:  Chem Biol       Date:  2003-02

10.  Antitumor activity of a kinesin inhibitor.

Authors:  Roman Sakowicz; Jeffrey T Finer; Christophe Beraud; Anne Crompton; Evan Lewis; Alex Fritsch; Yan Lee; John Mak; Robert Moody; Rebecca Turincio; John C Chabala; Paul Gonzales; Stephanie Roth; Steve Weitman; Kenneth W Wood
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

View more
  1 in total

1.  Antitumor Potential of the Isoflavonoids (+)- and (-)-2,3,9-Trimethoxypterocarpan: Mechanism-of-Action Studies.

Authors:  Kaio Farias; Roner F da Costa; Assuero S Meira; Jairo Diniz-Filho; Eveline M Bezerra; Valder N Freire; Prue Guest; Maryam Nikahd; Xinghua Ma; Michael G Gardiner; Martin G Banwell; Maria da C F de Oliveira; Manoel O de Moraes; Claudia do Ó Pessoa
Journal:  ACS Med Chem Lett       Date:  2020-05-20       Impact factor: 4.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.